Logo image of NBIX

NEUROCRINE BIOSCIENCES INC (NBIX) Stock Analyst Ratings

NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock - Currency: USD

106.73  +0.97 (+0.92%)

After market: 107.41 +0.68 (+0.64%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 166.45. This target is 55.95% above the current price.
NBIX was analyzed by 33 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
NBIX Historical Analyst RatingsNBIX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 10 20 30

Price Target & Forecast

Price Low Median Mean High 106.73139.38166.26166.45201.60 - 30.59% 55.78% 55.95% 88.89%
NBIX Current Analyst RatingNBIX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10
Up and Down Grades
Date Firm Action Rating
2025-04-24 Evercore ISI Group Maintains Outperform -> Outperform
2025-04-22 HC Wainwright & Co. Maintains Buy -> Buy
2025-04-15 Needham Upgrade Hold -> Buy
2025-04-14 RBC Capital Upgrade Sector Perform -> Outperform
2025-04-04 UBS Maintains Buy -> Buy
2025-03-26 JP Morgan Maintains Overweight -> Overweight
2025-02-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-10 Guggenheim Maintains Buy -> Buy
2025-02-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-07 Needham Reiterate Hold -> Hold
2025-02-07 RBC Capital Maintains Sector Perform -> Sector Perform
2025-02-07 Wedbush Maintains Outperform -> Outperform
2025-02-07 Canaccord Genuity Maintains Buy -> Buy
2025-02-07 B of A Securities Maintains Buy -> Buy
2025-02-07 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-04 Morgan Stanley Maintains Overweight -> Overweight
2025-01-30 UBS Maintains Buy -> Buy
2025-01-08 UBS Maintains Buy -> Buy
2024-12-23 Barclays Maintains Overweight -> Overweight
2024-12-23 Piper Sandler Reiterate Overweight -> Overweight
2024-12-20 Needham Reiterate Hold -> Hold
2024-12-16 Wedbush Reiterate Outperform -> Outperform
2024-12-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-11 Needham Reiterate Hold
2024-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 Needham Reiterate Hold
2024-10-30 Needham Reiterate Hold
2024-10-29 Needham Reiterate Hold
2024-10-17 BMO Capital Maintains Market Perform -> Market Perform